We have just taken delivery of a new Waters TQ-XS Triple Quadrupole Mass Spectrometer, coupled to an ACQUITY UPLC System with 2D LC Technology. The Weqas Reference Laboratory is the first clinical laboratory to have this Waters flagship instrument in the UK. Such an exciting acquisition will enable the Reference
News
News
Our marketing team are currently looking at organising regional EQA workshops which will cover EQA interpretation for basic level through to advanced level for both Lab and PoCT. Possible locations for 2017 are: Dublin, Edinburgh and Oxford. To register your interest in a regional workshop in your area please email
Weqas will be offering non-HDL Cholesterol as a new analyte as part of the Lipids programme. This will take effect from September distribution.
Annette Thomas, Weqas Director Earlier on this month, David and I attended an excellent meeting in Cardiff, on Traceability and Uncertainty organised by the All Wales Clinical Biochemistry Audit Group. Although no audits were presented, the organisers provided a forum for identifying best practice through a mix of formal presentations
David Ducroq, Deputy Director EQALM Barcelona 2016 Casa Milà La Boqueria Market Montjuic La Sagrada Familia Our lab manager, Samantha Jones and myself attended this important European meeting set in the vibrant city of Barcelona. The meeting is the annual forum for EQA providers to exchange ideas (sometimes argue) but
The Serum Indices programme has now been added to the Weqas interactive site. Currently (distribution IQQ) result entry and reports will only be available online. The latest serum Indices distribution (IQN), was the first trial of electronic reporting and has recently been released. Serum Indices Programme
As many of you are currently working towards compliance to ISO15189, Annette has written a post/blog on calculating your bias and imprecision for your uncertainty calculation, we hope you find this useful! How to calculate your long term bias for your uncertainty calculation?
From July 15th, we will no longer be processing Weqas EQA results received via post, fax or email. From this date, all results must be entered electronically by participants via the Weqas interactive user account: https://calc.weqas.com/ If you do not already have a Weqas interactive user account, please download the
The Weqas programme has been recently modified to predominantly distribute patient samples. Glycated Haemoglobin (HbA1c) is an established test for monitoring diabetic control and is recommended by the World Health Organisation for the diagnosis of Diabetes Mellitus, provided that stringent quality assurance tests are in place and assays are standardised
New vials for Weqas Co-oximetry scheme were recently introduced to overcome numerous issues with the previous design. We welcome your feedback on this design modification. To view a demonstration on how to use these vials, please use the link: https://www.eurotrol.com/video/acudrop
